1. Dai, Yan, Shaikho, Elmutaz M, Perez, Jessica, Sebastiani, Paola, Steinberg, Martin H. . BCL2L1 is associated with γ-globin gene expression. In Blood advances, 3, 2995-3001. doi:10.1182/bloodadvances.2019032243. https://pubmed.ncbi.nlm.nih.gov/31648320/
2. Beroukhim, Rameen, Mermel, Craig H, Porter, Dale, Sellers, William R, Meyerson, Matthew. . The landscape of somatic copy-number alteration across human cancers. In Nature, 463, 899-905. doi:10.1038/nature08822. https://pubmed.ncbi.nlm.nih.gov/20164920/
3. Yin, Ling, Hu, Xiaoding, Pei, Guangsheng, Feng, Xu, Chen, Junjie. 2024. Genome-wide CRISPR screen reveals the synthetic lethality between BCL2L1 inhibition and radiotherapy. In Life science alliance, 7, . doi:10.26508/lsa.202302353. https://pubmed.ncbi.nlm.nih.gov/38316463/
4. Izumi, Motohiro, Fujii, Masanori, Kobayashi, Ikei S, Costa, Daniel B, Kobayashi, Susumu S. 2024. Integrative single-cell RNA-seq and spatial transcriptomics analyses reveal diverse apoptosis-related gene expression profiles in EGFR-mutated lung cancer. In Cell death & disease, 15, 580. doi:10.1038/s41419-024-06940-y. https://pubmed.ncbi.nlm.nih.gov/39122703/
5. Guo, Ting, Gu, Chao, Li, Bin, Xu, Congjian. 2021. Dual inhibition of FGFR4 and BCL-xL inhibits multi-resistant ovarian cancer with BCL2L1 gain. In Aging, 13, 19750-19759. doi:10.18632/aging.203386. https://pubmed.ncbi.nlm.nih.gov/34351305/
6. Sillars-Hardebol, Anke H, Carvalho, Beatriz, Beliën, Jeroen Am, Fijneman, Remond Ja, Meijer, Gerrit A. 2011. BCL2L1 has a functional role in colorectal cancer and its protein expression is associated with chromosome 20q gain. In The Journal of pathology, 226, 442-50. doi:10.1002/path.2983. https://pubmed.ncbi.nlm.nih.gov/22009326/
智鼠故事 
